Predicting treatment-related cardiovascular risks in breast cancer patients: development and validation of an interpretable machine learning model
Frontiers in Oncology · 12.08.2026 · 16
DOI: 10.3389/fonc.2026.1814219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 12.08.2026. Verfasst von Luxin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
Purpose
This study aimed to develop and validate an interpretable machine learning model to predict the 1- to 3-year risk of cardiovascular events in breast cancer patients by integrating baseline and treatment variables, while preliminarily investigating the potential association between short-term cardiac function decline and long-term adverse cardiovascular events.
Methods
We analyzed electronic medical records from 31,878 breast cancer patients. A composite cardiovascular event outcome was used. Predictors were selected via a two-step process: removing highly correlated variables (|r|≥0.7) and applying LASSO regression with 10-fold cross-validation, which refined 62 initial variables down to 18. Five models were built and compared using the area under the receiver operating characteristic curve (AUC-ROC). The optimal model was interpreted using SHapley Additive exPlanations (SHAP).
Results
Among 31,878 breast cancer patients, 3,960 (12.4%) experienced cardiovascular events. The XGBoost model demonstrated the best overall discriminative performance (AUC = 0.790). SHAP analysis identified endocrine therapy, anemia management therapy, and history of cerebrovascular disease as the top three predictors. Crucially, short-term decline in cardiac function was also selected as a significant predictor, supporting its role as a precursor to long-term events. Model robustness was confirmed via sensitivity analysis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China.
- Internet Medical and System Applications of National Engineering Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zitieren
APA
Wang, L., Yan, R., Zhu, X., Yu, J., & Cui, F. (2026). Predicting treatment-related cardiovascular risks in breast cancer patients: development and validation of an interpretable machine learning model. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1814219
Vancouver
Wang L, Yan R, Zhu X, Yu J, Cui F. Predicting treatment-related cardiovascular risks in breast cancer patients: development and validation of an interpretable machine learning model. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1814219
BibTeX
@article{Wang2026,
author = {Wang, Luxin and Yan, Rui and Zhu, Xinyu and Yu, Jinming and Cui, Fangfang},
title = {Predicting treatment-related cardiovascular risks in breast cancer patients: development and validation of an interpretable machine learning model},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1814219}
}
EUVIMED